Anticoagulants are the cornerstone for prevention and treatment of thrombosis but are not
completely effective, and concerns about the risk of bleeding continue to limit their uptake …

PURPOSE To conduct an update of the ASCO venous thromboembolism (VTE) guideline.
METHODS After publication of potentially practice-changing clinical trials, identified through …

Gastrointestinal (GI) cancers comprise a significant number of cancer cases worldwide and
contribute to a high percentage of cancer-related deaths. To improve survival rates of GI …

Risks of recurrence and treatment-emergent bleeding are high in patients with cancer-
associated venous thromboembolism (VTE) but factors associated with these risks remain …

Patients diagnosed with cancer often experience an abnormal occurrence of venous
thromboembolism (VTE) and its related complications. In order to evaluate the safety and …

Background Patients with acute venous thromboembolism associated with cancer have an
increased risk of recurrences and bleeding in the long term. Research question To describe …

Background Patients with cancer-associated venous thromboembolism (VTE) have a high
risk of VTE recurrence and anticoagulant treatment–related bleeding, but the correlation of …

Abstract The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines
on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this …

Venous thromboembolism (VTE) is a common and potentially life-threatening complication
in patients with cancer. Both cancer and its treatments increase the risk of developing VTE …

Background The association between gastrointestinal (GI) cancer and a high incidence of
venous thromboembolism (VTE) is well known. Previous randomized controlled studies …